MariMed (OTCMKTS:MRMD) & Tsumura & Co. (OTCMKTS:TSMRF) Head to Head Analysis

Tsumura & Co. (OTCMKTS:TSMRF) and MariMed (OTCMKTS:MRMD) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, analyst recommendations, institutional ownership, earnings and profitability.

Profitability

This table compares Tsumura & Co. and MariMed’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tsumura & Co.	N/A	N/A	N/A
MariMed	-10.97%	-2.75%	-1.06%

Valuation and Earnings

This table compares Tsumura & Co. and MariMed”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tsumura & Co.	N/A	N/A	N/A	N/A	N/A
MariMed	$148.60 million	0.27	-$16.03 million	($0.02)	-5.21

Tsumura & Co. has higher earnings, but lower revenue than MariMed.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Tsumura & Co. and MariMed, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tsumura & Co.	0	0	0	0	0.00
MariMed	0	0	0	1	4.00

Insider & Institutional Ownership

22.3% of Tsumura & Co. shares are held by institutional investors. Comparatively, 0.2% of MariMed shares are held by institutional investors. 19.0% of MariMed shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

About Tsumura & Co.

Tsumura & Co. manufactures and sells pharmaceutical products worldwide. The company offers Kampo extract intermediates and granular Kampo formulations. It is involved in the procurement, selection and processing, and storage of raw material crude drugs and crude drug pieces for decoction; manufacture of Kampo powdered extracts and traditional Chinese medicines; and sale of pharmaceuticals and food products. The company was founded in 1893 and is headquartered in Tokyo, Japan.

About MariMed

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty’s Eddies brand and ice creams under Emack & Bolio’s brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.